Factors that should be taken into account when assessing the risk of TEs are the concomitance of other risk factors for thrombosis and for cardiovascular diseases, the presence of other autoimmune conditions, and the multiple positivity of aPL [15]. This evidence concerns the gene FASLG and deep vein thrombosis.